Health News
At the Medicap Pharmacy® stores, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.
Next Step for Failed Migraine Drug
MAP Pharmaceuticals will meet with U.S. Food and Drug Administration officials to clarify issues of concern after the agency failed to approve its investigational migraine inhaler just days ago.
Migraines Linked to Suicide Risk
Individuals who suffer from severe headaches, even if they're not migraines, are more likely to attempt suicide. Researchers said the increase could be due to the associated pain severity.
Soul Man's Soul Rests in Peace
Sweet Caroline. Dock of the Bay. Soul Man. Suspicious Minds. Angel of Harlem. Let's Stay Together. Mustang Sally. You know the singers, but do you know who played those soulful horns?
The Basics of Alzheimer’s Disease
According to the National Institute on Aging, an estimated 5.1 million Americans suffer from Alzheimer’s Disease. Symptoms typically develop in people over 60 and can interfere with daily life dramatically as the disease progresses.
Is it Really Alzheimer’s?
Correct diagnosis is key to the proper treatment of any disease. Alzheimer’s disease is responsible for 60%-80% of dementia cases, yet it is often misdiagnosed. New testing drugs are being created to increase diagnostic accuracy.
Mapping the Brain With Dementia
While finding effective treatments for Alzheimer's continues to challenge researchers, using MRI images to predict how the disease and other dementias spread may be closer at hand.
Tomosynthesis Useful for Spotting OA
Advances in technology have given us amazing ways to see inside a person's body. Using X-ray or MRI, doctors can diagnose patients without cutting into their bodies. Not all imaging techniques, though, are equal.
Controversial Alzheimer’s Testing Method
Alzheimer’s disease accounts for 60% to 80% of dementia cases, yet one in five cases are diagnosed as something else. Excluding Alzheimer's and looking for something else may be valuable to the patient.
New Drug for Alzheimer's Disease
The U.S. Food and Drug Administration approved Amyvid ( Florbetapir F 18 Injection) a drug for Positron Emission Tomography (PET) imaging of the brain in adults who are being evaluated for Alzheimer's Disease (AD) and other causes of cognitive decline.
Extending the use of Aricept for Alzheimer’s
Aricept ( donepezil ) is currently approved for mild to moderate Alzheimer’s Disease and is commonly taken by people in early stages of the disease. New research extends the use of the drug for people in moderate to severe stages of the disease.